Progestin-only hormonal methods (mini-pills, implants, and shots)ReferencesCitations Zieman M, et al. (2007). Managing Contraception for Your Pocket. Tiger, GA: Bridging the Gap
Foundation. Greydanus DE, et al. (2001). Contraception in the
adolescent: An update. Pediatrics, 107(3):
562–573. Trussell J (2004). The essentials of contraception:
Efficacy, safety, and personal considerations. In RA Hatcher et al., eds.,
Contraceptive Technology, 18th ed., pp. 221–252. New
York: Ardent Media. Hatcher RA (2004). Depo-Provera injections, implants,
and progestin-only pills (minipills). In RA Hatcher et al., eds.,
Contraceptive Technology, 18th ed., pp. 461–494. New
York: Ardent Media. U.S. Food and Drug Administration (2004). Black box
warning added concerning long-term use of Depo-Provera contraceptive injection.
FDA Talk Paper No. T04-50. Available online:
http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html. Scholes D, et al. (2005). Change in bone mineral
density among adolescent women using and discontinuing depot
medroxyprogesterone acetate contraception. Archives of Pediatrics and Adolescent Medicine, 159(2): 139–144. Morrison CS, et al. (2004). Hormonal contraceptive
use, cervical ectopy, and the acquisition of cervical infections.
Sexually Transmitted Diseases, 31(9):
561–567. Kjos SL, et al. (1998). Contraception and the risk of
type 2 diabetes mellitus in Latina women with prior gestational diabetes
mellitus. JAMA, 280(6): 533–538. Kahn HS, et al. (2003). Effects of injectable or
implantable progestin-only contraceptives on insulin-glucose metabolism and
diabetes risk. Diabetes Care, 26(1):
216–225. Hatcher RA, Nelson A (2004). Combined hormonal
contraceptive methods. In RA Hatcher et al., eds., Contraceptive Technology, 18th ed., pp. 391–460. New York:
Ardent Media.
| |